Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21606164 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: cyclosporine;   Other: flow cytometry;   Biological: anti-thymocyte globulin

Study has passed its completion date and status has not been verified in more than two years.